APO Research

APO RESEARCH · REPORT

Sodium Valproate

Selected research

Market Structure

Global Sodium Valproate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Sodium Valproate market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sodium Valproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sodium Valproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sodium Valproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sodium Valproate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sodium Valproate include Sanofi, Fresenius Kabi, AbbVie, Zentiva, Wockhardt, Hikma Farmaceutica, Desitin Pharmaceuticals and Athenex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sodium Valproate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sodium Valproate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sodium Valproate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sodium Valproate market size, projected growth trends, production technologies, key applications, and end-use industries.

Sodium Valproate Segment by Company

Sanofi

Fresenius Kabi

AbbVie

Zentiva

Wockhardt

Hikma Farmaceutica

Desitin Pharmaceuticals

Athenex

Sodium Valproate Segment by Type

Tablet

Liquid

Injection

Sodium Valproate Segment by Application

Epilepsy

Migraines

Others

Sodium Valproate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sodium Valproate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sodium Valproate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sodium Valproate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sodium Valproate market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sodium Valproate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sodium Valproate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sodium Valproate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sodium Valproate Industry Trends Table 2. Sodium Valproate Industry Drivers Table 3. Sodium Valproate Industry Opportunities and Challenges Table 4. Sodium Valproate Industry Restraints Table 5. Global Sodium Valproate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sodium Valproate Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sodium Valproate Sales by Manufacturers (W Tons) & (2021-2026) Table 8. Global Sodium Valproate Sales Market Share by Manufacturers Table 9. Global Sodium Valproate Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Sodium Valproate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sodium Valproate Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sodium Valproate Manufacturers, Product Type & Application Table 13. Global Sodium Valproate Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sodium Valproate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Liquid Table 18. Major Manufacturers of Injection Table 19. Global Sodium Valproate Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 20. Global Sodium Valproate Sales by Type (2021-2026) & (W Tons) Table 21. Global Sodium Valproate Sales by Type (2027-2032) & (W Tons) Table 22. Global Sodium Valproate Sales Market Share by Type (2021-2026) Table 23. Global Sodium Valproate Sales Market Share by Type (2027-2032) Table 24. Global Sodium Valproate Revenue by Type 2021 VS 2025 VS 2032 (W Tons) Table 25. Global Sodium Valproate Revenue by Type (2021-2026) & (W Tons) Table 26. Global Sodium Valproate Revenue by Type (2027-2032) & (W Tons) Table 27. Global Sodium Valproate Revenue Market Share by Type (2021-2026) Table 28. Global Sodium Valproate Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Epilepsy Table 30. Major Manufacturers of Migraines Table 31. Major Manufacturers of Others Table 32. Global Sodium Valproate Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 33. Global Sodium Valproate Sales by Application (2021-2026) & (W Tons) Table 34. Global Sodium Valproate Sales by Application (2027-2032) & (W Tons) Table 35. Global Sodium Valproate Sales Market Share by Application (2021-2026) Table 36. Global Sodium Valproate Sales Market Share by Application (2027-2032) Table 37. Global Sodium Valproate Revenue by Application 2021 VS 2025 VS 2032 (W Tons) Table 38. Global Sodium Valproate Revenue by Application (2021-2026) & (W Tons) Table 39. Global Sodium Valproate Revenue by Application (2027-2032) & (W Tons) Table 40. Global Sodium Valproate Revenue Market Share by Application (2021-2026) Table 41. Global Sodium Valproate Revenue Market Share by Application (2027-2032) Table 42. Global Sodium Valproate Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Table 43. Global Sodium Valproate Sales by Region (2021-2026) & (W Tons) Table 44. Global Sodium Valproate Sales Market Share by Region (2021-2026) Table 45. Global Sodium Valproate Sales Forecasted by Region (2027-2032) & (W Tons) Table 46. Global Sodium Valproate Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Sodium Valproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 48. North America Sodium Valproate Sales by Country (2021-2026) & (W Tons) Table 49. North America Sodium Valproate Sales by Country (2027-2032) & (W Tons) Table 50. Europe Sodium Valproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 51. Europe Sodium Valproate Sales by Country (2021-2026) & (W Tons) Table 52. Europe Sodium Valproate Sales by Country (2027-2032) & (W Tons) Table 53. Asia Pacific Sodium Valproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 54. Asia Pacific Sodium Valproate Sales by Country (2021-2026) & (W Tons) Table 55. Asia Pacific Sodium Valproate Sales by Country (2027-2032) & (W Tons) Table 56. South America, Middle East and Africa Sodium Valproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Tons) Table 57. South America, Middle East and Africa Sodium Valproate Sales by Country (2021-2026) & (W Tons) Table 58. South America, Middle East and Africa Sodium Valproate Sales by Country (2027-2032) & (W Tons) Table 59. Global Sodium Valproate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Sodium Valproate Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Sodium Valproate Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Sodium Valproate Revenue Market Share by Region (2021-2026) Table 63. Global Sodium Valproate Revenue Market Share by Region (2027-2032) Table 64. Sanofi Company Information Table 65. Sanofi Business Overview Table 66. Sanofi Sodium Valproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sanofi Sodium Valproate Product Portfolio Table 68. Sanofi Recent Development Table 69. Fresenius Kabi Company Information Table 70. Fresenius Kabi Business Overview Table 71. Fresenius Kabi Sodium Valproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Fresenius Kabi Sodium Valproate Product Portfolio Table 73. Fresenius Kabi Recent Development Table 74. AbbVie Company Information Table 75. AbbVie Business Overview Table 76. AbbVie Sodium Valproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. AbbVie Sodium Valproate Product Portfolio Table 78. AbbVie Recent Development Table 79. Zentiva Company Information Table 80. Zentiva Business Overview Table 81. Zentiva Sodium Valproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Zentiva Sodium Valproate Product Portfolio Table 83. Zentiva Recent Development Table 84. Wockhardt Company Information Table 85. Wockhardt Business Overview Table 86. Wockhardt Sodium Valproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Wockhardt Sodium Valproate Product Portfolio Table 88. Wockhardt Recent Development Table 89. Hikma Farmaceutica Company Information Table 90. Hikma Farmaceutica Business Overview Table 91. Hikma Farmaceutica Sodium Valproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Hikma Farmaceutica Sodium Valproate Product Portfolio Table 93. Hikma Farmaceutica Recent Development Table 94. Desitin Pharmaceuticals Company Information Table 95. Desitin Pharmaceuticals Business Overview Table 96. Desitin Pharmaceuticals Sodium Valproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Desitin Pharmaceuticals Sodium Valproate Product Portfolio Table 98. Desitin Pharmaceuticals Recent Development Table 99. Athenex Company Information Table 100. Athenex Business Overview Table 101. Athenex Sodium Valproate Sales (W Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Athenex Sodium Valproate Product Portfolio Table 103. Athenex Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Sodium Valproate Distributors List Table 107. Sodium Valproate Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Sodium Valproate Product Image Figure 2. Global Sodium Valproate Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sodium Valproate Market Size (2021-2032) & (US$ Million) Figure 4. Global Sodium Valproate Sales (2021-2032) & (W Tons) Figure 5. Global Sodium Valproate Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Sodium Valproate Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Liquid Image Figure 10. Injection Image Figure 11. Global Sodium Valproate Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 12. Global Sodium Valproate Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Sodium Valproate Sales Market Share by Type (2021-2032) Figure 14. Global Sodium Valproate Revenue by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 15. Global Sodium Valproate Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Sodium Valproate Revenue Market Share by Type (2021-2032) Figure 17. Epilepsy Image Figure 18. Migraines Image Figure 19. Others Image Figure 20. Global Sodium Valproate Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 21. Global Sodium Valproate Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Sodium Valproate Sales Market Share by Application (2021-2032) Figure 23. Global Sodium Valproate Revenue by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 24. Global Sodium Valproate Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Sodium Valproate Revenue Market Share by Application (2021-2032) Figure 26. North America Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 27. North America Sodium Valproate Sales Market Share by Country (2021-2032) Figure 28. U.S. Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 29. Canada Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 30. Mexico Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 31. Europe Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 32. Europe Sodium Valproate Sales Market Share by Country (2021-2032) Figure 33. Germany Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 34. France Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 35. U.K. Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 36. Italy Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 37. Netherlands Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 38. Asia Pacific Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 39. Asia Pacific Sodium Valproate Sales Market Share by Country (2021-2032) Figure 40. China Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 41. Japan Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 42. South Korea Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 43. Southeast Asia Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 44. India Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 45. Australia Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 46. South America, Middle East and Africa Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 47. South America, Middle East and Africa Sodium Valproate Sales Market Share by Country (2021-2032) Figure 48. Brazil Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 49. South Africa Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 50. Saudi Arabia Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 51. Turkey Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 52. Argentina Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 53. UAE Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 54. Egypt Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 55. Chile Sodium Valproate Sales and Growth Rate (2021-2032) & (W Tons) Figure 56. Global Sodium Valproate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Sodium Valproate Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Sodium Valproate Revenue (2021-2032) & (US$ Million) Figure 59. North America Sodium Valproate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Sodium Valproate Revenue (2021-2032) & (US$ Million) Figure 61. Europe Sodium Valproate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Sodium Valproate Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Sodium Valproate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Sodium Valproate Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Sodium Valproate Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Sodium Valproate Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Sodium Valproate Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Liquid
  • Injection
Applications
  • Epilepsy
  • Migraines
  • Others
Companies covered
  • Sanofi
  • Fresenius Kabi
  • AbbVie
  • Zentiva
  • Wockhardt
  • Hikma Farmaceutica
  • Desitin Pharmaceuticals
  • Athenex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sodium Valproate Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sodium Valproate Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sodium Valproate Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sodium Valproate Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sodium Valproate Market Dynamics
  1. 2.1 Sodium Valproate Industry Trends
  2. 2.2 Sodium Valproate Industry Drivers
  3. 2.3 Sodium Valproate Industry Opportunities and Challenges
  4. 2.4 Sodium Valproate Industry Restraints
3 Sodium Valproate Market by Manufacturers
  1. 3.1 Global Sodium Valproate Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sodium Valproate Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sodium Valproate Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sodium Valproate Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sodium Valproate Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sodium Valproate Manufacturers, Product Type & Application
  7. 3.7 Global Sodium Valproate Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sodium Valproate Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sodium Valproate Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sodium Valproate Tier 1, Tier 2, and Tier 3
4 Sodium Valproate Market by Type
  1. 4.1 Sodium Valproate Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Liquid
  4. 4.1.3 Injection
  5. 4.2 Global Sodium Valproate Sales by Type
  6. 4.2.1 Global Sodium Valproate Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Sodium Valproate Sales by Type (2021-2032)
  8. 4.2.3 Global Sodium Valproate Sales Market Share by Type (2021-2032)
  9. 4.3 Global Sodium Valproate Revenue by Type
  10. 4.3.1 Global Sodium Valproate Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Sodium Valproate Revenue by Type (2021-2032)
  12. 4.3.3 Global Sodium Valproate Revenue Market Share by Type (2021-2032)
5 Sodium Valproate Market by Application
  1. 5.1 Sodium Valproate Application Introduction
  2. 5.1.1 Epilepsy
  3. 5.1.2 Migraines
  4. 5.1.3 Others
  5. 5.2 Global Sodium Valproate Sales by Application
  6. 5.2.1 Global Sodium Valproate Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sodium Valproate Sales by Application (2021-2032)
  8. 5.2.3 Global Sodium Valproate Sales Market Share by Application (2021-2032)
  9. 5.3 Global Sodium Valproate Revenue by Application
  10. 5.3.1 Global Sodium Valproate Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sodium Valproate Revenue by Application (2021-2032)
  12. 5.3.3 Global Sodium Valproate Revenue Market Share by Application (2021-2032)
6 Global Sodium Valproate Sales by Region
  1. 6.1 Global Sodium Valproate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sodium Valproate Sales by Region (2021-2032)
  3. 6.2.1 Global Sodium Valproate Sales by Region (2021-2026)
  4. 6.2.2 Global Sodium Valproate Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sodium Valproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sodium Valproate Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sodium Valproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sodium Valproate Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sodium Valproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sodium Valproate Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sodium Valproate Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sodium Valproate Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sodium Valproate Revenue by Region
  1. 7.1 Global Sodium Valproate Revenue by Region
  2. 7.1.1 Global Sodium Valproate Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sodium Valproate Revenue by Region (2021-2026)
  4. 7.1.3 Global Sodium Valproate Revenue by Region (2027-2032)
  5. 7.1.4 Global Sodium Valproate Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sodium Valproate Revenue (2021-2032)
  8. 7.2.2 North America Sodium Valproate Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sodium Valproate Revenue (2021-2032)
  11. 7.3.2 Europe Sodium Valproate Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sodium Valproate Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sodium Valproate Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sodium Valproate Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sodium Valproate Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Sodium Valproate Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Sodium Valproate Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Fresenius Kabi
  8. 8.2.1 Fresenius Kabi Company Information
  9. 8.2.2 Fresenius Kabi Business Overview
  10. 8.2.3 Fresenius Kabi Sodium Valproate Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Fresenius Kabi Sodium Valproate Product Portfolio
  12. 8.2.5 Fresenius Kabi Recent Developments
  13. 8.3 AbbVie
  14. 8.3.1 AbbVie Company Information
  15. 8.3.2 AbbVie Business Overview
  16. 8.3.3 AbbVie Sodium Valproate Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AbbVie Sodium Valproate Product Portfolio
  18. 8.3.5 AbbVie Recent Developments
  19. 8.4 Zentiva
  20. 8.4.1 Zentiva Company Information
  21. 8.4.2 Zentiva Business Overview
  22. 8.4.3 Zentiva Sodium Valproate Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Zentiva Sodium Valproate Product Portfolio
  24. 8.4.5 Zentiva Recent Developments
  25. 8.5 Wockhardt
  26. 8.5.1 Wockhardt Company Information
  27. 8.5.2 Wockhardt Business Overview
  28. 8.5.3 Wockhardt Sodium Valproate Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wockhardt Sodium Valproate Product Portfolio
  30. 8.5.5 Wockhardt Recent Developments
  31. 8.6 Hikma Farmaceutica
  32. 8.6.1 Hikma Farmaceutica Company Information
  33. 8.6.2 Hikma Farmaceutica Business Overview
  34. 8.6.3 Hikma Farmaceutica Sodium Valproate Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hikma Farmaceutica Sodium Valproate Product Portfolio
  36. 8.6.5 Hikma Farmaceutica Recent Developments
  37. 8.7 Desitin Pharmaceuticals
  38. 8.7.1 Desitin Pharmaceuticals Company Information
  39. 8.7.2 Desitin Pharmaceuticals Business Overview
  40. 8.7.3 Desitin Pharmaceuticals Sodium Valproate Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Desitin Pharmaceuticals Sodium Valproate Product Portfolio
  42. 8.7.5 Desitin Pharmaceuticals Recent Developments
  43. 8.8 Athenex
  44. 8.8.1 Athenex Company Information
  45. 8.8.2 Athenex Business Overview
  46. 8.8.3 Athenex Sodium Valproate Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Athenex Sodium Valproate Product Portfolio
  48. 8.8.5 Athenex Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sodium Valproate Value Chain Analysis
  2. 9.1.1 Sodium Valproate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sodium Valproate Production Mode & Process
  6. 9.2 Sodium Valproate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sodium Valproate Distributors
  9. 9.2.3 Sodium Valproate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research